SCHEMBL7079812

SCHEMBL7079812

COc1cc(C=C(P(=O)(OC(C)C)OC(C)C)P(=O)(OC(C)C)OC(C)C)cc(OC)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.63
KMT2A Q03164 7/20 0.47
MAPT P10636 5/20 0.47
GAA P10253 2/20 0.47
CYP3A4 P08684 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2B6 P20813 2/20 0.44
CYP2D6 P10635 1/20 0.44
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
PTP4A3 O75365 1/20 0.41
PTP4A2 Q12974 1/20 0.41
PTP4A1 Q93096 1/20 0.41
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41
MEN1 O00255 4/20 0.41
EGFR P00533 4/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7526155 0.88 HMGCR (0.56) HMGCRKMT2AMAPTGAACYP3A4
SCHEMBL19403369 0.81 HMGCR (0.58) HMGCRKMT2AMAPTGAACYP1A2
SCHEMBL7134489 0.80 HMGCR (0.65) HMGCRGAACYP3A4CYP1A2CYP2B6
SCHEMBL7522505 0.79 KMT2A (0.55) KMT2AMAPTGAACYP3A4CYP1A2
SCHEMBL7083232 0.79 NR1I2 (0.63) HMGCRKMT2AMAPTGAACYP3A4
SCHEMBL7080302 0.78 HMGCR (1.00) HMGCRKMT2AMAPTGAACYP3A4
SCHEMBL19398038 0.77 HMGCR (0.48) HMGCRKMT2AGAACYP1A2CYP2C9
SCHEMBL19403348 0.77 HMGCR (0.47) HMGCRKMT2AMAPTGAACYP3A4
SCHEMBL19398041 0.77 HMGCR (0.53) HMGCRKMT2AMAPTCYP3A4CYP1A2
SCHEMBL8660505 0.76 HMGCR (0.44) HMGCRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326618-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES Ilex Oncology Research S.A. (CH) 2003-07-16 EP claimed
WO-2002011704-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES SYMPHAR S.A. (CH) 2002-02-14 WO claimed
EP-0845991-B1 USE OF PHENOL SUBSTITUTED DIPHOSPHONATES AS ANTINEOPLASTIC AGENTS SYMPHAR SA (CH) 2002-02-06 EP claimed